Cargando…
A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy
Introduction: This systematic review analyzes the state-of-art repurposing of the drug tamoxifen (TAM) in the treatment of Duchenne Muscular Dystrophy (DMD), including its mechanism of action, toxicological findings, and past and ongoing clinical trials. A parallel aim of this work was to explore wh...
Autores principales: | Botti, Valeria, Menzel, Olivier, Staedler, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709317/ https://www.ncbi.nlm.nih.gov/pubmed/36467064 http://dx.doi.org/10.3389/fphar.2022.1030785 |
Ejemplares similares
-
Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021) -
Drug development progress in duchenne muscular dystrophy
por: Deng, Jiexin, et al.
Publicado: (2022) -
Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy
por: Markati, Theodora, et al.
Publicado: (2021) -
Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
por: Ogura, Yuji, et al.
Publicado: (2014) -
CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)